Scarlet, which certifies AI and medical‑device software, raises $50 million Series B to fund US and Asia‑Pacific expansion
funding
| Source: Techmeme | Original article
London-based Scarlet, which certifies AI and software for medical devices, secured a $50 million Series B round led by Headline to fund its expansion into the US and Asia‑Pacific.
London‑based Scarlet, a specialist certification body for AI‑driven and software‑based medical devices, announced a $50 million Series B round led by venture firm Headline. The financing also includes new investor Notion Capital and existing backers Atomico, Creandum, Kindred Capital and Entrepreneurs First, with Headline partner Nancy Xiao McLaughlin joining Scarlet’s board.
The capital is earmarked for Scarlet’s expansion into the United States and the Asia‑Pacific region, where demand for rapid, trustworthy approval of AI‑powered health technologies is growing. As one of the few regulators‑authorised entities in Europe and the UK that focuses exclusively on software and AI, Scarlet aims to streamline the traditionally lengthy certification process, helping developers bring innovations to patients more quickly while ensuring safety and compliance.
The raise underscores the broader market’s recognition that AI is becoming integral to medical devices, yet regulatory pathways have struggled to keep pace. By offering a dedicated, expert‑led assessment service, Scarlet could become a critical bridge between medtech startups and health authorities, potentially accelerating adoption of AI diagnostics, monitoring tools and therapeutic algorithms.
Going forward, observers will watch how Scarlet establishes a foothold in the highly regulated US and diverse Asia‑Pacific markets, whether it secures partnerships with local health agencies, and how its presence influences the speed and standards of AI medical device approvals. The move also raises questions about competitive dynamics among certification providers and the possible emergence of new regulatory frameworks tailored to AI‑centric health technologies.
Sources
Back to AIPULSEN